151 related articles for article (PubMed ID: 31486705)
1. Non-inferiority tests for binary endpoints with variable margins.
Ren Y; Wang C; Shen M; Tsong Y
J Biopharm Stat; 2019; 29(5):822-833. PubMed ID: 31486705
[TBL] [Abstract][Full Text] [Related]
2. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
[TBL] [Abstract][Full Text] [Related]
3. Non-inferiority test for a continuous variable with a flexible margin in an active controlled trial: an application to the "Stratall ANRS 12110 / ESTHER" trial.
Sandie AB; Molinari N; Wanjoya A; Kouanfack C; Laurent C; Tchatchueng-Mbougua JB
Trials; 2022 Mar; 23(1):202. PubMed ID: 35248123
[TBL] [Abstract][Full Text] [Related]
4. A note on the determination of non-inferiority margins with application in oncology clinical trials.
Yu B; Yang H; Sabin A
Contemp Clin Trials Commun; 2019 Dec; 16():100454. PubMed ID: 31650074
[TBL] [Abstract][Full Text] [Related]
5. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
Tang NS; Yu B; Tang ML
BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
[TBL] [Abstract][Full Text] [Related]
6. Non-inferiority tests for anti-infective drugs using control group quantiles.
Fay MP; Follmann DA
Clin Trials; 2016 Dec; 13(6):632-640. PubMed ID: 27430709
[TBL] [Abstract][Full Text] [Related]
7. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.
Althunian TA; de Boer A; Klungel OH; Insani WN; Groenwold RH
Trials; 2017 Mar; 18(1):107. PubMed ID: 28270184
[TBL] [Abstract][Full Text] [Related]
8. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
Weir IR; Trinquart L
Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
[TBL] [Abstract][Full Text] [Related]
9. Non-inferiority margins employed in clinical trials in Japan.
Gosho M
J Clin Pharm Ther; 2015 Jun; 40(3):289-98. PubMed ID: 25827098
[TBL] [Abstract][Full Text] [Related]
10. Design and analysis of non-inferiority mortality trials in oncology.
Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
[TBL] [Abstract][Full Text] [Related]
11. Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials.
Bikdeli B; Caraballo C; Welsh J; Ross JS; Kaul S; Stone GW; Krumholz HM
Clin Trials; 2020 Dec; 17(6):723-728. PubMed ID: 32838556
[TBL] [Abstract][Full Text] [Related]
12. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
Hida E; Tango T
J Biopharm Stat; 2013; 23(4):774-89. PubMed ID: 23799810
[TBL] [Abstract][Full Text] [Related]
13. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
Li Z; Quartagno M; Böhringer S; van Geloven N
Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
[TBL] [Abstract][Full Text] [Related]
14. Non-inferiority testing with a variable margin.
Zhang Z
Biom J; 2006 Dec; 48(6):948-65. PubMed ID: 17240654
[TBL] [Abstract][Full Text] [Related]
15. Tests for noninferiority trials with binomial endpoints: A guide to modern and quasi-exact methods for biomedical researchers.
Ripamonti E; Lloyd CJ
Pharm Stat; 2019 May; 18(3):377-387. PubMed ID: 30689280
[TBL] [Abstract][Full Text] [Related]
16. Issues on the selection of non-inferiority margin in clinical trials.
Hou Y; Wu XY; Li K
Chin Med J (Engl); 2009 Feb; 122(4):466-70. PubMed ID: 19302756
[TBL] [Abstract][Full Text] [Related]
17. Exploring how non-inferiority and equivalence are assessed in paediatrics: a systematic review.
Aupiais C; Zohar S; Taverny G; Le Roux E; Boulkedid R; Alberti C
Arch Dis Child; 2018 Nov; 103(11):1067-1075. PubMed ID: 29794107
[TBL] [Abstract][Full Text] [Related]
18. A ratio test in active control non-inferiority trials with a time-to-event endpoint.
Wang YC; Chen G; Chi GY
J Biopharm Stat; 2006; 16(2):151-64. PubMed ID: 16584064
[TBL] [Abstract][Full Text] [Related]
19. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
Ghosh S; Tiwari RC; Ghosh S
Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of matched pair designs with two binary endpoints.
Jiang Y; Xu J
Stat Methods Med Res; 2017 Dec; 26(6):2526-2542. PubMed ID: 26294329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
